Low-Dose Cyclophosphamide Synergizes with Dendritic Cell-Based Immunotherapy in Antitumor Activity

Clinical immunotherapy trials like dendritic cell-based vaccinations are hampered by the tumor's offensive repertoire that suppresses the incoming effector cells. Regulatory T cells are instrumental in suppressing the function of cytotoxic T cells. We studied the effect of low-dose cyclophospha...

Descripción completa

Detalles Bibliográficos
Autores principales: Veltman, Joris D., Lambers, Margaretha E. H., van Nimwegen, Menno, de Jong, Sanne, Hendriks, Rudi W., Hoogsteden, Henk C., Aerts, Joachim G. J. V., Hegmans, Joost P. J. J.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874992/
https://www.ncbi.nlm.nih.gov/pubmed/20508851
http://dx.doi.org/10.1155/2010/798467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874992/
https://www.ncbi.nlm.nih.gov/pubmed/20508851
http://dx.doi.org/10.1155/2010/798467

Ejemplares similares